Jul 2026
RMI2 knockdown suppresses ovarian cancer cell growth by impairing DNA damage repair via the ATR/CHK1 signaling pathway.
RMI2 may promote OC development by activating the ATR/CHK1 pathway to sustain genomic stability, highlighting its potential as a prognostic biomarker and therapeutic target in OC.
Kean Zhu, Zhao Li, Yingying Wei et al.
· In vitro Cellular & Developm... · 0 citations